Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai populationArticle Published on 2022-12-312023-07-08 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), [키워드] AZD1222 ChAdOx1 COVID-19 vaccine immunogenicity Safety single-dose vaccine. [DOI] 10.1080/21645515.2022.2035573 PMC 바로가기
Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 diseaseArticle Published on 2022-12-302023-07-11 Journal: Virology Journal [Category] COVID19(2023년), [키워드] ACE2 aptamer COVID-19 neutralization RBD Safety SARS-CoV-2 Spike S protein Toxicity virus. VLP [DOI] 10.1186/s12985-022-01943-7 PMC 바로가기
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in ChildrenArticle Published on 2022-12-202023-07-10 Journal: mBio [Category] COVID19(2023년), [키워드] CoronaVac COVID-19 immunogenicity pediatric phase 3 clinical trial Safety SARS-CoV-2 Vaccines variants of concern. [DOI] 10.1128/mbio.01311-22 PMC 바로가기
Relevance of prediction scores derived from the SARS-CoV-2 first wave, in the evolving UK COVID-19 second wave, for safe early discharge and mortality: a PREDICT COVID-19 UK prospective observational cohort studyObservational Study Published on 2022-12-202023-07-11 Journal: BMJ Open [Category] COVID19(2023년), [키워드] COVID-19 general medicine (see internal medicine) health & Organisation of health services Safety telemedicine. [DOI] 10.1136/bmjopen-2021-054469 PMC 바로가기 [Article Type] Observational Study
An EUA for anakinra (Kineret) for COVID-19Article Published on 2022-12-122023-07-11 Journal: The Medical letter on drugs and therapeutics [Category] COVID19(2023년), [키워드] actemra adverse effects Anakinra Baricitinib Corticosteroids COVID-19 Dexamethasone dosage Drug interactions Efficacy lactation Olumiant Pregnancy Remdesivir Safety tocilizumab. Veklury PMC 바로가기
Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in ChinaClinical Trial Published on 2022-12-082023-06-14 Journal: Frontiers in Immunology [Category] Fulltext, 신종인플루엔자, [키워드] Coadministration immunogenicity inactivated enterovirus 71 vaccine Safety trivalent split-virion inactivated influenza vaccine. [DOI] 10.3389/fimmu.2022.1080408 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 Vaccination in Korea: Past, Present, and the Way ForwardReview Published on 2022-12-052023-07-11 Journal: Journal of Korean medical science [Category] COVID19(2023년), [키워드] COVID-19 Safety SARS-CoV-2 vaccination vaccine efficacy. [DOI] 10.3346/jkms.2022.37.e351 PMC 바로가기 [Article Type] Review
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIVHIV 보균자에서 비활성화된 SARS-CoV-2 백신의 안전성 및 면역원성Observational Study Published on 2022-12-012022-09-12 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] adverse event age Analysis binding domain booster dose CD4 CD4 count CD4 counts Cell COVID-19 declined Efficacy enrolled evaluated Factor Frequency Gender geometric GMT healthy control healthy controls HIV humoral humoral immune response IgG immune immune response Immunocompromised in both groups inactivated Inactivated vaccine less MBC memory B occurred Patient PLWH predicted prospective observational study reduced remained reported response responses robust Safety Safety. SARS-CoV-2 SARS-CoV-2 vaccine Serious Adverse Event Seven significantly vaccination Viral load with HIV [DOI] 10.1080/22221751.2022.2059401 PMC 바로가기 [Article Type] Observational Study
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysisMeta-Analysis Published on 2022-12-012023-06-01 Journal: European Journal of Clinical Pharmacology [Category] 두창, 수두, 홍역, [키워드] atopic dermatitis jak inhibitors Meta-analysis Safety systematic review. [DOI] 10.1007/s00228-022-03400-4 PMC 바로가기 [Article Type] Meta-Analysis
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron wavesArticle Published on 2022-12-012022-11-16 Journal: Journal of Neurology [Category] COVID19(2023년), SARS, 변종, [키워드] Administered Affect Alpha BNT162b2 mRNA BNT162b2 mRNA vaccine contribute COVID-19 COVID-19 mortality COVID-19 vaccine develop disease General population Mild morbidity and mortality Myasthenia myasthenia gravis outcome Patient patients raise reduced risk Respiratory failure risk risk of COVID-19 Safety SARS-CoV-2 SARS-CoV-2 variants severe COVID-19 severe disease significantly higher vaccination Vaccine vaccine dose vaccine. [DOI] 10.1007/s00415-022-11303-8 PMC 바로가기